IM Lorazepam Dosing for Catatonia
For catatonia with agitation and pacing, administer lorazepam 2 mg IM initially, which can be repeated every 10-15 minutes if needed, with a typical dosing range of 2-4 mg IM per dose, administered up to three times daily (TID) as clinically indicated. 1
Initial IM Dosing Strategy
- Start with 2 mg IM lorazepam as the initial dose, which aligns with standard preanesthetic IM dosing (0.05 mg/kg up to maximum 4 mg) 1
- The IM route is appropriate when IV access is unavailable, though therapeutic levels are reached more slowly than with IV administration 1
- For catatonia specifically, clinical studies demonstrate that 2 mg IM lorazepam administered once or twice within the first 2 hours achieves an 85.7% complete remission rate 2, 3
TID Dosing Protocol
- Administer 2-4 mg IM every 8 hours (TID) based on clinical response, with doses repeated every 10-15 minutes during acute episodes if catatonic signs persist 4, 1
- The maximum single IM dose should not exceed 4 mg per administration 1
- Total daily doses in catatonia treatment studies have ranged from 3-8 mg/day orally, suggesting that 6-12 mg/day IM (2-4 mg TID) is a reasonable and safe range 5
Critical Monitoring Requirements
- Continuously monitor oxygen saturation due to increased risk of apnea, particularly when benzodiazepines are combined with other sedatives 6, 7
- Respiratory support equipment must be immediately available at bedside 6, 4
- Monitor for hypotension, especially in elderly or frail patients 4, 7
- Watch for paradoxical agitation, which can occasionally occur 4
Response Assessment and Next Steps
- Assess response within the first 2 hours - early response to lorazepam predicts final outcome 5, 2
- If no improvement after 1-2 days of adequate lorazepam dosing (typically 3-6 mg/day for at least 3 days), consider escalation to ECT 5, 8
- Complete resolution of catatonic symptoms occurs in 32-70% of patients with lorazepam alone, with partial improvement in up to 68.7% 5, 8
- If lorazepam fails, diazepam IV infusion (10 mg in 500 mL normal saline every 8 hours) can be considered as an alternative benzodiazepine strategy 2, 3
Common Pitfalls to Avoid
- Do not underdose - inadequate dosing (less than 3 mg/day) reduces response rates significantly 5, 8
- Do not delay ECT consultation if patient fails to respond after 3-5 days of adequate benzodiazepine trial 5, 8
- Avoid oral administration during acute catatonic episodes with decreased responsiveness due to aspiration risk 6
- Do not use flumazenil to reverse sedation, as it will precipitate symptom recurrence 6
Special Population Considerations
- Elderly patients require dose reduction to 0.05-0.1 mg/kg due to decreased metabolism and higher respiratory depression risk 4
- Adjust dosing in patients with hepatic or renal impairment, particularly with frequent repeated doses 4, 1
- No specific dose adjustment needed for single acute doses in renal disease, but exercise caution with repeated dosing 1